Login / Signup

Is the elimination of 'sleeping sickness' affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa.

C Simone SutherlandFabrizio Tedisio
Published in: BMJ global health (2019)
Overall, the total costs of either control or elimination programme would be near US$1 billion in the next decade. However, only elimination programme will reduce the number of cases and improve financial risk protection for households who are impacted by HAT Tbg.
Keyphrases
  • endothelial cells
  • healthcare
  • young adults
  • induced pluripotent stem cells